Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

NCT00644059 ·Status: COMPLETED ·Phase: PHASE3

Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)

NCT00310648 ·Status: COMPLETED ·Phase: PHASE3

Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults

NCT01701752 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

NCT00329927 ·Status: COMPLETED ·Phase: PHASE2

Comparison of 4 Influenza Vaccines in Seniors

NCT01368796 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012

NCT01344057 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older

NCT00782431 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

NCT06087640 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Th1 Response to Influenza: Aging and Vaccine Efficacy

NCT00396305 ·Status: TERMINATED ·Phase: PHASE4

Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly

NCT00296829 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly Subjects

NCT01422512 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine

NCT01265914 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects

NCT01357265 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older

NCT00848848 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of a Inactivated Influenza Vaccine When Administered to Non Elderly Adults and Elderly Subjects.

NCT00316615 ·Status: COMPLETED ·Phase: PHASE2

Mood and Influenza Vaccine Response: A Feasibility Trial

NCT03144518 ·Status: COMPLETED ·Phase: NA

CT18 Infant Influenza Priming Study in Vaccine Naive Infants

NCT03669627 ·Status: COMPLETED ·Phase: PHASE2

Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners

NCT01207518 ·Status: UNKNOWN ·Phase: NA

A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64

NCT00695669 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Non-Elderly Adult and Elderly Subjects

NCT01356316 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects

NCT01162122 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects

NCT00481065 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of A/H1N1v Vaccines in Healthy Adults

NCT00943358 ·Status: COMPLETED ·Phase: PHASE1

Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?

NCT01001325 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study

NCT00644540 ·Status: COMPLETED ·Phase: PHASE2